NCT06456580 2026-03-10
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Vor Biopharma
Phase 3 Recruiting
Vor Biopharma
The Children's Hospital of Zhejiang University School of Medicine
RemeGen Co., Ltd.
RemeGen Co., Ltd.